Circulating levels of leptin and adiponectin is correlated with the risk of various cancers include breast, endometrial, colon/gastric and prostate cancers (Yang WS et al. 2002; Petridou E et al. 2003; Miyoshi Y et al. 2003). Here, LEP is linked to prostate cancer.